Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2025-12-25 @ 6:06 PM
Study NCT ID:
NCT00361959
Status:
COMPLETED
Last Update Posted:
2017-01-20
First Post:
2006-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-06
Start Date Type:
ACTUAL
Primary Completion Date:
2006-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-08-07
First Submit QC Date:
None
Study First Post Date:
2006-08-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-19
Last Update Post Date:
2017-01-20
Last Update Post Date Type:
ESTIMATED